U.S. stocks traded mostly higher on Tuesday after a March inflation report turned out not as bad as some traders feared, but the impact of a halt to the rollout of Johnson & Johnson vaccine kept optimism in check.
The S&P 500 added 0.33% to finish at 4,141.59 and locked in a new closing high.
The Nasdaq Composite, the relative outperformer, gained just over 1% to 13,996.1 as Apple and PayPal each added more than 2%. Semiconductor maker Nvidia climbed 3%, Tesla rose 8.6%.
The Dow Jones Industrial Average fell 68.13 points, 0.2%, to close at 33,677.27 after dropping more than 150 points earlier in the session.
Reopening trades came under pressure Tuesday morning after the U.S. Food and Drug Administration said it’s recommending a pause in the Johnson & Johnson Covid-19 vaccine after reported cases of blood clotting.
There have been six reported cases of a rare and severe type of blood clot after receiving the J&J vaccine, the FDA said. The administration is calling for a pause in the vaccine until Centers for Disease Control and Prevention concludes its investigation into these cases.
Reference: CNBC
Thai
Eng